GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InflaRx NV (NAS:IFRX) » Definitions » Pretax Margin %

InflaRx NV (InflaRx NV) Pretax Margin % : -868,600.00% (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is InflaRx NV Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. InflaRx NV's Pre-Tax Income for the three months ended in Dec. 2023 was $-17.37 Mil. InflaRx NV's Revenue for the three months ended in Dec. 2023 was $0.00 Mil. Therefore, InflaRx NV's pretax margin for the quarter that ended in Dec. 2023 was -868,600.00%.

The historical rank and industry rank for InflaRx NV's Pretax Margin % or its related term are showing as below:

IFRX' s Pretax Margin % Range Over the Past 10 Years
Min: -68771.64   Med: -67434.78   Max: -67434.78
Current: -68771.64


IFRX's Pretax Margin % is ranked worse than
97.27% of 1027 companies
in the Biotechnology industry
Industry Median: -176.72 vs IFRX: -68771.64

InflaRx NV Pretax Margin % Historical Data

The historical data trend for InflaRx NV's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InflaRx NV Pretax Margin % Chart

InflaRx NV Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only - - - - -67,434.78

InflaRx NV Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -12,233.85 -868,600.00

Competitive Comparison of InflaRx NV's Pretax Margin %

For the Biotechnology subindustry, InflaRx NV's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InflaRx NV's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, InflaRx NV's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where InflaRx NV's Pretax Margin % falls into.



InflaRx NV Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

InflaRx NV's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-46.53/0.069
=-67,434.78 %

InflaRx NV's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-17.372/0.002
=-868,600.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


InflaRx NV  (NAS:IFRX) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


InflaRx NV Pretax Margin % Related Terms

Thank you for viewing the detailed overview of InflaRx NV's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


InflaRx NV (InflaRx NV) Business Description

Traded in Other Exchanges
Address
Winzerlaer Strasse 2, Jena, DEU, 07745
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its lead product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.